Allyum advises Havea on acquisition of ixX Pharma

Havea accelerates the international development of Aragan with the acquisition of ixX pharma in Belgium

Havea Group (“Havea”), one of the European leaders in natural health products with revenues of € 200m, backed by its reference shareholders 3i Group, announces the acquisition of ixX pharma, a key Belgian player in food supplements distributed in the pharmacy channel. With the combination of the expertise of its brand Aragan in the French market and of ixX pharma in the Belgian market, Havea supports Aragan’s international development and capitalizes on the common DNA of these two premium food supplements brands, based on a scientific approach, the naturality of its products and advice from pharmacists. The acquisition of ixX pharma also reinforces Havea’s presence in Belgium, already present through its brands Densmore & Vitavea. 

For more informations and details about this deal, please find attached the press release related to this article.

About Allyum

Allyum is a corporate finance company which advises companies on financial transactions, fundraisings, IPO and Mergers & Acquisitions. With a multi-skilled team, Allyum is a key partner, understanding the challenges of its clients and providing them with financial recommendations. More than 200 companies have entrusted Allyum to conduct their financial transactions in Belgium and in other countries over the last 16 years. For more information, visit www.allyum.com